European Union - English - EMA (European Medicines Agency)

bayer ag - darolutamide - prostatic neoplasms, castration-resistant - endocrine therapy - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5.1).- metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.1).

European Union - English - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasms, castration-resistant - antineoplastic agents - treatment of adult patients with prostate cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - conifer phytosterol complex,d-alpha-tocopherol,epimedium sagittatum,serenoa repens,zinc citrate -

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - cabazitaxel - prostatic neoplasms - antineoplastic agents - jevtana in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - cabazitaxel - prostatic neoplasms, castration-resistant - antineoplastic agents - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

Australia - English - Department of Health (Therapeutic Goods Administration)

well herb pty ltd - astragalus membranaceus,colophony,curcuma zedoaria,lycopus lucidus,oldenlandia diffusa,patrinia villosa,phellodendron amurense,plantago afra,taraxacum mongolicum -

Australia - English - Department of Health (Therapeutic Goods Administration)

v alliance global pty ltd - cucurbita pepo,lycopersicon esculentum,serenoa repens -

Australia - English - Department of Health (Therapeutic Goods Administration)

md solutions australasia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

good health products australia - lycopersicon esculentum, quantity: 60 mg (equivalent: lycopersicon esculentum, qty 6 g; equivalent: steroidal alkaloids calculated as solanine, qty 0.3 mg); serenoa repens, quantity: 320 mg (equivalent: serenoa repens, qty 4 g); urtica dioica, quantity: 120 mg (equivalent: urtica dioica, qty 1.2 g); zinc amino acid chelate, quantity: 40 mg (equivalent: zinc, qty 8 mg); selenomethionine, quantity: 0.101 mg (equivalent: selenium, qty 40 microgram); cucurbita moschata, quantity: 25 mg (equivalent: cucurbita moschata, qty 250 mg); colecalciferol, quantity: 24 microgram - capsule, hard - excipient ingredients: maltodextrin; silicon dioxide; calcium phosphate; starch sodium octenyl succinate; dl-alpha-tocopherol; ascorbic acid; sunflower oil; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; acacia; hypromellose; rice; citric acid; glycine - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support reproductive system health ; help maintain/support healthy prostate function ; helps enhance/promote prostate health ; maintain/support prostate health ; maintain/support sperm production ; relieve urinary frequency ; enhance/promote/increase urine output ; maintain/support healthy urine output

Australia - English - Department of Health (Therapeutic Goods Administration)

blueskygreenearth herbs pty ltd - urtica dioica, quantity: 80 mg (equivalent: urtica dioica, qty 480 mg); boric acid, quantity: 700 microgram (equivalent: boron, qty 122.43 microgram); serenoa repens, quantity: 39.3 mg (equivalent: serenoa repens, qty 235.8 mg; equivalent: sitosterol, qty 39.3 mg); serenoa repens, quantity: 100 mg (equivalent: serenoa repens, qty 600 mg); ligustrum lucidum, quantity: 20 mg (equivalent: ligustrum lucidum, qty 120 mg); anemone altaica, quantity: 50 mg (equivalent: anemone altaica, qty 300 mg); lindera strychnifolia, quantity: 50 mg (equivalent: lindera strychnifolia, qty 300 mg); boswellia serrata, quantity: 30 mg (equivalent: boswellia serrata, qty 180 mg; equivalent: boswellic acid, qty 10 mg); dioscorea collettii var. hypoglauca, quantity: 80 mg (equivalent: dioscorea collettii var. hypoglauca, qty 480 mg); alpinia hainanensis, quantity: 50 mg (equivalent: alpinia hainanensis, qty 300 mg) - capsule, hard - excipient ingredients: gelatin; titanium dioxide - traditionally used in western herbal medicine to maintain/support reproductive system health ; traditionally used in western herbal medicine to maintain/support urogenital health